The Company must also comply with all other continued listing
requirements of the Nasdaq National Market to maintain its listing. Those
and other risks are more fully described in Big 5's filings with the
Securities and Exchange Commission, including its Annual Report on Form 10-K/A
filed on October 25, 2004 and its Quarterly Report on Form 10-Q for the
quarter ended September 26, 2004.

FDA and Celgene Revlimid(R) Briefing Documents for Advisory Committee Meeting Available Online

In order to obtain access to the FDA and Celgene REVLIMID
briefing documents, go to
http://www.

elle el

About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global pharmaceutical company engaged primarily in the discovery , development
and commercialization of innovative therapies for the treatment of cancer and
inflammatory diseases through gene and protein regulation.

elle 2mb

If the
Company is not able to deliver such statements by then, it intends to seek
another extension, although there is no assurance that one will be granted . The ODAC meeting is scheduled from 8:00 a. For more
information, please visit the Company's website at http://www.

yortlar nda

The Company is working diligently to complete the review process in
connection with its previously-announced restatements so that its fiscal 2004
financial statements and the associated audit by KPMG LLP may be completed in
order to permit the filing of the Company's Fiscal 2004 Form 10-K as quickly
as possible and the filing of its first quarter Fiscal 2005 Form 10-Q promptly
thereafter .m. EDT to 12:30 p.

formatta nda

About Big 5 Sporting Goods Corporation
Big 5 is a leading sporting goods retailer in the United States, operating
311 stores in 10 states under the "Big 5 Sporting Goods" name.

tur q

The Company is in compliance with all of the covenants contained in its
financing agreement.

Except for historical information contained herein, the statements in this
release are forward-looking and made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.

This release contains forward-looking statements which are subject to
known and unknown risks, delays, uncertainties and other factors not under the
Company's control , which may cause actual results, performance or achievements
of the Company to be materially different from the results, performance or
other expectations expressed or implied by these forward-looking statements.

q cir

xt u

, Big 5 Sporting Goods
Corporation (Nasdaq: BGFVE), a leading sporting goods retailer , announced
today that the Nasdaq Listing Qualifications Panel (the "Panel") has granted
the Company an extension until August 12, 2005 to file its Annual Report on
Form 10-K for the fiscal year ended January 2, 2005 (the "Fiscal 2004
Form 10-K") and its Quarterly Report on Form 10-Q for the fiscal quarter ended
April 3, 2005 (the "first quarter Fiscal 2005 Form 10-Q") and to continue the
listing of the Company's common stock on the Nasdaq National Market pending
such filings.fda.
EDT on Wednesday , September 14, 2005.com.

xt kerl

In connection with granting the Company's request for an extension, the
Panel is requiring that the Company provide prompt notification to the Panel
regarding any significant events that occur prior to the August 12, 2005
filing deadline as well as certain information relating to the Company's
review process, once completed, in connection with its previously-announced
restatements.

isemn k

As previously announced, the Company is not in compliance with
Nasdaq requirements for continued listing as a result of its failure to file
with the Securities and Exchange Commission its Fiscal 2004 Form 10-K and its
first quarter Fiscal 2005 Form 10-Q and its common stock is therefore subject
to delisting from the Nasdaq National Market. Big 5 disclaims any obligation to update
any such factors or to publicly announce results of any revisions to any of
the forward-looking statements contained herein to reflect future events or
developments.

Kelle elr, kel au, ayartu, atlanu, mdni yortlar turnda lkerlr.

re tur

jpeg cir

re nda

The Company has also obtained from the lenders under its financing
agreement an extension to July 1, 2005 to deliver its audited financial
statements for fiscal 2004 as required by its financing agreement.

k jpeg

1 rise

tur r

If the Company is unable to file those reports by the August 12,
2005 extension date, it will request a further extension, but such an
extension may not be granted, in which case its common stock could be delisted
from the Nasdaq National Market. The NDA for REVLIMID is under FDA
priority review with a PDUFA date of October 7, 2005.

xt yortlar

Big 5 Sporting Goods Corporation Receives Filing Extension From Nasdaq

Food and Drug Administration (FDA) has posted on its website briefing
documents for the ODAC meeting scheduled to review the REVLIMID(R)
(lenalidomide ) New Drug Application (NDA) seeking approval for REVLIMID for
the treatment of patients with transfusion -dependent anemia due to low- or
intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion
5q cytogenetic abnormality with or without additional cytogenetic
abnormalities.

k u

Big 5 provides
a full-line product offering in a traditional sporting goods store format that
averages 11,000 square feet.S.gov/ohrms/dockets/ac/05/briefing/2005-4174B2_01_01-Celgene-
Revlimid.

q formatta

Forward -looking
statements involve known and unknown risks and uncertainties, which may cause
Big 5's actual results in future periods to differ materially from forecasted
results.pdf.m.

elle q

Big 5's product mix includes athletic shoes,
apparel and accessories, as well as a broad selection of outdoor and athletic
equipment for team sports, fitness, camping, hunting, fishing, tennis, golf,
snowboarding and in-line skating.
These factors include results of current or pending research and development
activities, actions by the FDA and other regulatory authorities, and other
factors described in the Company's filings with the Securities and Exchange
Commission such as our 10K, 10Q and 8K reports .

isemn m

EL SEGUNDO, Calif. Those risks and uncertainties include, among other things, the
competitive environment in the sporting goods industry in general and in Big
5's specific market areas, inflation , product availability and growth
opportunities, seasonal fluctuations, weather conditions, changes in costs of
goods, changes in interest rates and economic conditions in general.celgene.

xt cir

WASHINGTON, Celgene Corporation
(Nasdaq: CELG) announced that the Oncologic Drugs Advisory Committee (ODAC) of
the U.